JP2014522570A5 - - Google Patents

Download PDF

Info

Publication number
JP2014522570A5
JP2014522570A5 JP2014513075A JP2014513075A JP2014522570A5 JP 2014522570 A5 JP2014522570 A5 JP 2014522570A5 JP 2014513075 A JP2014513075 A JP 2014513075A JP 2014513075 A JP2014513075 A JP 2014513075A JP 2014522570 A5 JP2014522570 A5 JP 2014522570A5
Authority
JP
Japan
Prior art keywords
atoms
linear
branched
alkyl
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014513075A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014522570A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/002180 external-priority patent/WO2012163490A1/en
Publication of JP2014522570A publication Critical patent/JP2014522570A/ja
Publication of JP2014522570A5 publication Critical patent/JP2014522570A5/ja
Pending legal-status Critical Current

Links

JP2014513075A 2011-05-31 2012-05-23 電解質配合物 Pending JP2014522570A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11004433 2011-05-31
EP11004433.6 2011-05-31
PCT/EP2012/002180 WO2012163490A1 (en) 2011-05-31 2012-05-23 Electrolyte formulations

Publications (2)

Publication Number Publication Date
JP2014522570A JP2014522570A (ja) 2014-09-04
JP2014522570A5 true JP2014522570A5 (cg-RX-API-DMAC10.html) 2016-12-28

Family

ID=46201554

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014513075A Pending JP2014522570A (ja) 2011-05-31 2012-05-23 電解質配合物

Country Status (8)

Country Link
US (1) US20140182680A1 (cg-RX-API-DMAC10.html)
EP (1) EP2715858A1 (cg-RX-API-DMAC10.html)
JP (1) JP2014522570A (cg-RX-API-DMAC10.html)
KR (1) KR20140039242A (cg-RX-API-DMAC10.html)
CN (1) CN103597646A (cg-RX-API-DMAC10.html)
AU (1) AU2012265220A1 (cg-RX-API-DMAC10.html)
TW (1) TW201311709A (cg-RX-API-DMAC10.html)
WO (1) WO2012163490A1 (cg-RX-API-DMAC10.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014082706A1 (en) * 2012-11-30 2014-06-05 Merck Patent Gmbh Cobalt complexes with tricyanoborate or dicyanoborate counter-anions for electrochemical or optoelectronic devices
DE102013009959A1 (de) 2013-06-14 2014-12-31 Julius-Maximilians-Universität Würzburg Verfahren zur Herstellung von Salzen mit Hydridocyanoborat-Anionen
DE102014008131A1 (de) 2014-06-06 2015-12-17 Julius-Maximilians-Universität Würzburg Verfahren zur Herstellung von Salzen mit Monoydridocyanoborat-Anionen
DE102014011089A1 (de) 2014-07-30 2016-02-04 Julius-Maximilians-Universität Würzburg Verfahren zur Herstellung von Salzen mit Hydridocyanoborat-Anionen
US9828347B2 (en) 2014-10-09 2017-11-28 The United States Of America As Represented By The Secretary Of The Air Force Backfunctionalized imidazolinium salts and NHC carbene-metal complexes
DE102014016681A1 (de) 2014-11-12 2016-05-12 Julius-Maximilians-Universität Würzburg Verfahren zur Herstellung von Salzen mit Hydridocyanoborat-Anionen
JP6842821B2 (ja) * 2015-04-02 2021-03-17 株式会社トーキン 固体電解コンデンサ
US10392347B2 (en) 2015-10-14 2019-08-27 Bristol-Myers Squibb Company 2,4-dihydroxy-nicotinamides as APJ agonists
EP3390400B1 (en) 2015-12-16 2021-01-20 Bristol-Myers Squibb Company Heteroarylhydroxypyrimidinones as agonists of the apj receptor
WO2017123826A1 (en) 2016-01-14 2017-07-20 Beth Israel Deaconess Medical Center, Inc. Mast-cell modulators and uses thereof
MY189454A (en) 2016-03-24 2022-02-14 Bristol Myers Squibb Co 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as apj agonists
GB2554119A (en) * 2016-06-22 2018-03-28 Merck Patent Gmbh Stable electrolyte formulations
DE102016009846A1 (de) 2016-08-16 2018-02-22 Julius-Maximilians-Universität Würzburg Fluoralkylhydrido- und Fluoralkylcyanohydridoborate
US20190393555A1 (en) * 2017-01-31 2019-12-26 The School Corporation Kansai University Electrolyte solution, secondary battery and method for producing electrolyte solution
KR102009598B1 (ko) * 2018-02-27 2019-08-09 울산과학기술원 광-에너지 전환/저장 효율이 향상된 염료감응형 자가충전 광 화학전지 및 그 제조방법
DE102019109188B4 (de) * 2019-04-08 2022-08-11 Umicore Galvanotechnik Gmbh Verwendung eines Elektrolyten zur Abscheidung von anthrazit/schwarzen Rhodium/Ruthenium Legierungsschichten
US12590298B2 (en) 2019-10-18 2026-03-31 The Regents Of The University Of California Ex vivo tumor angiogenesis model
US11884647B2 (en) 2019-10-18 2024-01-30 The Regents Of The University Of California Compounds and methods for targeting pathogenic blood vessels
JP7378601B2 (ja) 2020-02-21 2023-11-13 エルジー エナジー ソリューション リミテッド リチウム二次電池用非水電解液及びそれを含むリチウム二次電池
SMT202500447T1 (it) 2021-11-02 2026-01-12 Flare Therapeutics Inc Agonisti inversi di pparg e loro usi
CN119768393A (zh) 2022-05-25 2025-04-04 医肯纳肿瘤学公司 Mek抑制剂和其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69115688T2 (de) 1990-04-17 1996-08-14 Ecole Polytech Photovoltaische zellen
EP0737358B1 (fr) 1993-12-29 1999-02-03 Ecole Polytechnique Federale De Lausanne Pile photo-electrochimique et electrolyte pour cette pile
JP2000090991A (ja) 1998-09-09 2000-03-31 Fuji Photo Film Co Ltd 光電気化学電池
DE60123714T2 (de) 2000-08-15 2007-10-04 FUJI PHOTO FILM CO., LTD., Minamiashigara Photoelektrische Zelle und Herstellungsmethode
EP1507307B9 (en) 2002-05-20 2008-08-13 Matsushita Electric Works, Ltd. Photoelectric conversion device
DE10306617A1 (de) 2003-02-14 2004-08-26 Merck Patent Gmbh Salze mit Cyanoborat-Anionen
EP1819005A1 (en) 2006-02-13 2007-08-15 Ecole Polytechnique Fédérale de Lausanne (EPFL) Ionic liquid electrolyte
WO2008102661A1 (ja) 2007-02-03 2008-08-28 Toyo Kasei Kogyo Co., Ltd. トリアルキルシリルニトリルの製造方法
US20100291374A1 (en) * 2007-06-12 2010-11-18 Ajjer Llc Composites Comprising Nanoparticles
CN101232080B (zh) 2007-12-29 2012-11-07 中国科学院长春应用化学研究所 共熔室温离子液体及其制法和应用
JP5876327B2 (ja) * 2011-03-07 2016-03-02 株式会社日本触媒 電解質材料並びにそれを用いた電池用材料及び二次電池

Similar Documents

Publication Publication Date Title
JP2014005303A5 (cg-RX-API-DMAC10.html)
JP2016520672A5 (cg-RX-API-DMAC10.html)
JP2010530373A5 (cg-RX-API-DMAC10.html)
JP2016515560A5 (cg-RX-API-DMAC10.html)
EP4643945A3 (en) Neuroactive steroids and methods of use thereof
WO2015011119A3 (en) Salts of dasatinib in amorphous form
RU2015139688A (ru) Композиция для косметического использования, пригодная для оказания пигментирующего воздействия на волосы
JP2007308696A5 (cg-RX-API-DMAC10.html)
RU2014117188A (ru) Способ получения производных 4,4-дифтор-3,4-дигидроизохинолина
JP2013010749A5 (ja) カルバゾール化合物
JP2010280669A5 (cg-RX-API-DMAC10.html)
JP2017022134A5 (ja) イオン液体、化合物、非水溶媒、電解液
BR112015010779A2 (pt) moduladores de di-hidropirazol gpr40
AR088296A1 (es) Citramida de rasagilina, proceso de preparación y composicion farmaceutica
WO2015114395A9 (en) Process for the preparation of vortioxetine salts
WO2014045260A3 (en) Multi component mixture of magnesiumcoholates, magnesiumhalides and alcohol, processes to make them and their use in processes to make olefin polymerization catalyst
BR112015021386A2 (pt) moduladores de ácido biciclo [2.2.2] gpr120
JP2016523246A5 (cg-RX-API-DMAC10.html)
JP2015191797A5 (cg-RX-API-DMAC10.html)
IN2015DN00837A (cg-RX-API-DMAC10.html)
JP2018521056A5 (cg-RX-API-DMAC10.html)
WO2015011120A3 (en) Salts of dasatinib in crystalline form
BR112015028740A2 (pt) processo para preparar dicarbamatos de 1,4:3,6-dianidroexitóis, composto químico precursor, composto químico derivado a partir de pelo menos um dos compostos químicos precursores, e, método de preparação de um composto químico derivado a partir de pelo menos um dos compostos químicos precursores
JP2014196484A5 (cg-RX-API-DMAC10.html)
JP2014508714A5 (cg-RX-API-DMAC10.html)